Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 16 May 2022 for Immunic, INC., €17k.
Filing timeline
BuySaleAndreas Muehler
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Andreas Muehler: trading record in brief
This profile gathers the share dealings of Andreas Muehler in Immunic, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 2 March 2021 to 12 May 2022, the count stands at 2 filings.
The open-market record is one-sided, with 2 purchases worth €146k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2022: 1 purchase and no sales on the market.
The latest filing, published on 16 May 2022, reports an open-market purchase of €17k in Immunic, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andreas Muehler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
3,500 shares@ US$5.10100.0% of flowCommon StockSEC:0001193805-22-000800:0
Canonical exit: 10 Aug 2022 (T+90)
1 of 1 declaration
